SV

Street Verdict

Analyst Scorecard

A record of what Narendra Solanki said publicly, with the source. Not advice.

“Narendra Solanki is constructive on the healthcare sector, particularly hospitals, and anticipates a gradual turnaround in pharma manufacturing. He identifies upcoming GLP-1 patent expiries in early 2026 in major markets like India and Brazil, alongside opportunities in complex generics, as key catalysts for the sector.”
Nifty Healthcare IndexBullishCalled 07 Jan 2026
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Narendra Solanki’s full track record